LONDON --�I'm always searching for shares that can help ordinary investors like you make money from the stock market.
So right now I am trawling through the FTSE 100 and giving my verdict on every member of the blue-chip index. Simply put, I'm hoping to pinpoint the very best buying opportunities in today's uncertain market.
Today I am looking at�Legal & General� (LSE: LGEN ) (NASDAQOTH: LGGNY ) to determine whether you should consider buying the shares at 168 pence.
I am assessing each company on several ratios:
Price/Earnings (P/E):�Does the share look like a good value when compared against its competitors?
Price earnings growth (PEG):�Does the share look good value factoring in predicted growth?
Yield:�Does the share provide a solid income for investors?
Dividend cover:�Is the dividend sustainable?
Let's look at the numbers:
Stock Price 3-Yr. EPS Growth Projected P/E PEG Yield 3-Yr. Dividend Growth Dividend Cover Legal & General 168p 0% 11.4 1.4 4.6% 61% 1.8The consensus analyst estimate for next year's earnings per share is 14.8 pence (8% growth) and dividend per share is 8.3 pence (9% growth).
Top 10 Restaurant Companies To Own For 2015: The Cushing MLP Total Return Fund(SRV)
Cushing MLP Total Return Fund is a closed-end mutual fund launched by Swank Capital, LLC. The fund is managed by Swank Energy Income Advisors L.P. It invests in the public equity and fixed income markets across the globe with a focus in United States. The fund typically invests in MLPs, Other Natural Resource Companies, and global commodities. It primarily invests in the securities of MLPs, other equity securities, debt securities, and securities of non-U.S. issuers employing a fundamental analysis. Cushing MLP Total Return Fund was formed on May 23, 2007 and is domiciled in Dallas.
Advisors' Opinion:- [By Robert Rapier]
As I write this, Tortoise Pipeline and Energy (NYSE: TTP) trades at a discount of 15.1 percent to its underlying assets, while at the other end of the spectrum Cushing MLP Total Return Fund (NYSE: SRV) trades at a 17.4 percent premium. The average MLP closed-end fund listed trades at a 4.9 percent discount, which is perhaps reasonable given the loss of certain tax advantages and the fact that management fees will eat into returns.
- [By Robert Rapier]
As I write this, Tortoise Pipeline and Energy (NYSE: TTP) trades at a discount of 15.1 percent to its underlying assets, while at the other end of the spectrum Cushing MLP Total Return Fund (NYSE: SRV) trades at a 17.4 percent premium. The average MLP closed-end fund listed trades at a 4.9 percent discount, which is perhaps reasonable given the loss of certain tax advantages and the fact that management fees will eat into returns.
Hot Income Stocks To Watch For 2014: Rofin-Sinar Technologies Inc.(RSTI)
Rofin-Sinar Technologies Inc., together with its subsidiaries, engages in the design, development, engineering, manufacturing, and marketing of laser-based products worldwide. The company offers laser macro products to machine tool and automotive markets for cutting and welding of metals. It also provides laser marking products to semiconductor and electronics markets for the marking of integrated circuits, wafers, solar cells, electronic components, and smart cards, as well as to automotive markets for the marking of labels and car components. In addition, the company offers laser micro products for fine welding, fine cutting, micro structuring, and drilling applications in medical devices, semiconductor and electronics, photovoltaic, dental, and jewelry markets; and for perforating and scribing of paper and foils in packaging and paper industries. Further, it provides components to laser industry. The company sells its products in approximately 65 countries to original e quipment manufacturers, systems integrators, and industrial end-users. Rofin-Sinar Technologies Inc. was founded in 1975 and is based in Plymouth, Michigan.
Advisors' Opinion:- [By Brian Stoffel]
Rofin-Sinar (NASDAQ: RSTI ) , Coherent (NASDAQ: COHR ) , Newport (NASDAQ: NEWP ) , and JDS Uniphase (NASDAQ: JDSU ) all offer fiber-optic lasers as well.
- [By Brian Stoffel]
For decades, the standard technology in the laser industry has been the carbon-based laser. In reality, these lasers are still commonly used, and sold in bulk by the likes of Rofin-Sinar (NASDAQ: RSTI ) and Coherent (NASDAQ: COHR ) . They are used largely for precision cutting of large pieces of metal.
Hot Income Stocks To Watch For 2014: Grupo Simec S.A. de C.V. (SIM)
Grupo Simec, S.A.B. de C.V., together with its subsidiaries, engages in the manufacture, processing, and distribution of special bar quality (SBQ) steel and structural products primarily in the United States, Mexico, and Canada. Its steel products include I-beams; channels; structural and commercial angles; hot rolled bars, such as round, square, and hexagonal rods; flat bars; rebars; cold finished bars; wire rods; semi-finished tube rounds; and other semi-finished trade products. The company�s SBQ products are used in various engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment; and structural steel products are used in the non-residential construction market and other construction applications, as well as automotive industries. It also operates in Latin America, Europe, and Asia. The company was founded in 1969 and is headquartered in Guadalajara, Mexico. Grupo Simec, S.A.B. d e C.V. is a subsidiary of Industrias CH, S.A.B. de C.V.
Advisors' Opinion:- [By Daniel Cross]
Grupo Simec (NYSE: SIM) is a relatively obscure company with a $1.7 billion market cap that makes special bar-quality steel for North American markets. The company has significant downside protection in the form of its cash and cash equivalents of $623 million and total liabilities of just $665 million. Simec is also aggressively buying back stock. On a technical level, the relative strength index is hovering around 31, signaling that the stock may be oversold.
Hot Income Stocks To Watch For 2014: Alnylam Pharmaceuticals Inc.(ALNY)
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up early in the day, but settling on a gain of 40.40 percent to $92.96 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.
Hot Income Stocks To Watch For 2014: Federated Investors Inc. (FII)
Federated Investors, Inc. is a publicly owned investment manager. The firm provides its services to individuals, including high net worth individuals, banking or thrift institutions, investment companies, pension and profit sharing plans, pooled investment vehicles, charitable organizations, state or municipal government entities, and registered investment advisors. Through its subsidiaries, it manages separate client-focused equity, fixed income, and money market mutual funds and separate client-focused equity, fixed income, and balanced portfolios. The firm invests in the public equity and fixed income markets across the globe. It invests in growth and value stocks of small-cap, mid-cap, and large-cap companies. The firm makes its fixed income investments in ultra-short, short-term, and intermediate-term mortgage-backed, U.S. Government, U.S. Corporate, high yield, and municipal securities. It employs a fundamental and a quantitative analysis to make its equity investmen ts. The firm also makes sector-focused equity investments. Federated Investors was founded in 1955 and is based in Pittsburgh, Pennsylvania with an additional office in New York, New York.
Advisors' Opinion:- [By Ben Levisohn]
But there are winners–and they’re any stock that’s helped by higher rates. There are mutual fund companies with big money-market fund businesses, who wouldn’t be forced to run these funds for what is essentially free. Federated Investors (FII), for instance, has jumped 2.1% to $27.99. Life insurance companies, too, are rising because they should be able to earn more on their investments. MetLife (MET), for instance, has risen 1.3% to $53.03.
No comments:
Post a Comment